chr16-3600989-G-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032444.4(SLX4):c.1153C>A(p.Pro385Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,613,620 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P385P) has been classified as Likely benign.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLX4 | NM_032444.4 | c.1153C>A | p.Pro385Thr | missense_variant | Exon 5 of 15 | ENST00000294008.4 | NP_115820.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLX4 | ENST00000294008.4 | c.1153C>A | p.Pro385Thr | missense_variant | Exon 5 of 15 | 5 | NM_032444.4 | ENSP00000294008.3 | ||
| SLX4 | ENST00000466154.5 | n.2374C>A | non_coding_transcript_exon_variant | Exon 3 of 7 | 1 | |||||
| SLX4 | ENST00000486524.1 | n.2707C>A | non_coding_transcript_exon_variant | Exon 4 of 4 | 2 | |||||
| SLX4 | ENST00000697858.1 | n.494C>A | non_coding_transcript_exon_variant | Exon 3 of 3 |
Frequencies
GnomAD3 genomes AF: 0.00915 AC: 1392AN: 152078Hom.: 20 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00376 AC: 942AN: 250206 AF XY: 0.00318 show subpopulations
GnomAD4 exome AF: 0.00236 AC: 3449AN: 1461424Hom.: 20 Cov.: 31 AF XY: 0.00231 AC XY: 1678AN XY: 727024 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00918 AC: 1397AN: 152196Hom.: 20 Cov.: 31 AF XY: 0.00867 AC XY: 645AN XY: 74422 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker.
not provided Benign:3
Fanconi anemia complementation group P Benign:2
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Fanconi anemia Benign:1
Hereditary cancer-predisposing syndrome Benign:1
BA1, BP4_Moderate c.1153C>A located in exon 5 of the SLX4 gene, is predicted to result in the substitution of proline with threonine at codon 385, p.(Pro385Thr). The variant allele was found in 644/23562 alleles (13 homozygous), with a filter allele frequency of 2.5% at 99% confidence, within the African population in the gnomAD v2.1.1 database (non-cancer data set)(BA1). The SpliceAI algorithm predicts no significant impact on splicing and the REVEL meta-predictor score for this variant (0.044) suggests that it does not affect the protein function according to Pejaver 2022 thresholds (PMID: 36413997)(BP4_Moderate). To our knowledge, neither relevant clinical data nor functional studies have been reported for this variant. This variant has been identified in the ClinVar database (5x likely benign, 4x benign) but has not been identified in the LOVD database. Based on currently available information, c.1153C>A is classified as a benign variant according ACMG guidelines.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at